MedPage Today RheumatologyPhysicians.....get the latest breaking news on Rheumatology. Free CME, accredited by the University of Pennsylvannia, is available for physicians and other medical professionals.High Birth Weight Linked to Rheumatoid Arthritis Risk- June 30, 2008 NEW YORK -- Babies weighing 10 pounds or more at birth have a significantly greater risk of rheumatoid arthritis when they grow up, data from the Nurses' Health Study suggested.http://www.medpagetoday.com/Rheumatology/Arthritis/tb/9963 Hip Replacement Leads to Improved Physical Functioning in Older Patients- June 19, 2008 DURHAM, N.C. -- Osteoarthritic hips even in older Medicare patients are likely to respond to arthroplasty with invigorated physical functioning, researchers here found.http://www.medpagetoday.com/Geriatrics/Arthritis/tb/9877 EULAR: Abatacept (Orencia) More Durable in RA than Infliximab (Remicade)- June 16, 2008 PARIS -- Two different biologic approaches to rheumatoid arthritis -- abatacept (Orencia) and infliximab (Remicade) -- have roughly equivalent efficacy if methotrexate fails, a researcher said here.http://www.medpagetoday.com/Rheumatology/Arthritis/tb/9835 EULAR: Fish Rich in Omega-3 May Reduce RA Risk- June 16, 2008 PARIS -- Eating oily fish at least once a month may help fend off rheumatoid arthritis, a large observational study has suggested.http://www.medpagetoday.com/Rheumatology/Arthritis/tb/9832 FDA Approves Duloxetine (Cymbalta) for Fibromyalgia- June 16, 2008 INDIANAPOLIS -- The FDA has approved duloxetine (Cymbalta), a serotonin-norepinphrine reuptake inhibitor, for fibromyalgia, the drug-maker said today.http://www.medpagetoday.com/ProductAlert/Prescriptions/tb/9830 EULAR: Joint Distraction Buys Time against Knee Replacement for Osteoarthritis- June 13, 2008 PARIS -- Mechanical joint distraction for osteoarthritic knees can restore near-normal function and help patients put off joint replacement, perhaps for years, according to a small study reported here.http://www.medpagetoday.com/Rheumatology/Arthritis/tb/9821 EULAR: Less Toxic Regimen Preserves Fertility in Women with Lupus- June 13, 2008 PARIS -- Five to seven months of treatment with cyclophosphamide (Cytoxan, Neosar) followed by mycophenolate mofetil was an effective -- and fertility-sparing -- treatment for young women with systemic lupus erythematosus (SLE), researchers reported here.http://www.medpagetoday.com/Rheumatology/Lupus/tb/9820 EULAR: Tocilizumab (Actemra) Demonstrates Efficacy in Anti-TNF Refractory RA Patients- June 13, 2008 PARIS -- An investigational compound, tocilizumab (Actemra), appears to be an effective option for rheumatoid arthritis patients who are refractory to anti-tumor necrosis factor therapy, researchers reported here.http://www.medpagetoday.com/Rheumatology/Arthritis/tb/9815 EULAR: Lupus Severity Greater with Southern European Ancestry- June 12, 2008 PARIS -- A lupus patient whose European ancestors were from Greece and its environs is more likely to have severe disease than one whose family hailed from Scandinavia, researchers here reported.http://www.medpagetoday.com/Rheumatology/Lupus/tb/9807 |